These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35880397)

  • 1. Prediction of pathologic complete response prediction in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy: A real-world study.
    Feng J; Wang L; Yang X; Chen Q; Cheng X
    Biomol Biomed; 2023 Feb; 23(1):153-160. PubMed ID: 35880397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic Complete Response Prediction to Neoadjuvant Immunotherapy Combined with Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: Real-World Evidence from Integrative Inflammatory and Nutritional Scores.
    Feng J; Wang L; Yang X; Chen Q; Cheng X
    J Inflamm Res; 2022; 15():3783-3796. PubMed ID: 35832830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel immune-nutritional score predicts response to neoadjuvant immunochemotherapy after minimally invasive esophagectomy for esophageal squamous cell carcinoma.
    Feng J; Wang L; Yang X; Chen Q; Cheng X
    Front Immunol; 2023; 14():1217967. PubMed ID: 37954582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma.
    Yang Y; Xin D; Wang H; Guan L; Meng X; Lu T; Bai X; Wang F
    J Inflamm Res; 2023; 16():1443-1455. PubMed ID: 37042015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte-monocyte ratio as a predictive marker for pathological complete response to neoadjuvant therapy in esophageal squamous cell carcinoma.
    Zhao K; Wang C; Shi F; Li M; Yu J
    Transl Cancer Res; 2020 Jun; 9(6):3842-3853. PubMed ID: 35117751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of pretreatment controlling nutritional status score for predicting recurrence in patients with esophageal squamous cell carcinoma undergoing neoadjuvant immunochemotherapy: A real-world study.
    Feng J; Wang L; Yang X; Chen Q; Cheng X
    Front Immunol; 2022; 13():1015365. PubMed ID: 36505443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining serum inflammation indexes at baseline and post treatment could predict pathological efficacy to anti‑PD‑1 combined with neoadjuvant chemotherapy in esophageal squamous cell carcinoma.
    Zhang X; Gari A; Li M; Chen J; Qu C; Zhang L; Chen J
    J Transl Med; 2022 Feb; 20(1):61. PubMed ID: 35109887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combined nomogram based on radiomics and hematology to predict the pathological complete response of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.
    Yang Y; Yi Y; Wang Z; Li S; Zhang B; Sang Z; Zhang L; Cao Q; Li B
    BMC Cancer; 2024 Apr; 24(1):460. PubMed ID: 38609892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment Pan-Immune-Inflammation Value (PIV) in Predicting Therapeutic Response and Clinical Outcomes of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma.
    Feng J; Wang L; Yang X; Chen Q; Cheng X
    Ann Surg Oncol; 2024 Jan; 31(1):272-283. PubMed ID: 37838648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort.
    Qi WX; Wang X; Li C; Li S; Li H; Xu F; Chen J; Zhao S; Li H
    Thorac Cancer; 2023 Jun; 14(17):1556-1566. PubMed ID: 37089116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma.
    Xu L; Wei XF; Li CJ; Yang ZY; Yu YK; Li HM; Xie HN; Yang YF; Jing WW; Wang Z; Kang XZ; Zhang RX; Qin JJ; Xue LY; Bi N; Chen XK; Li Y
    Front Immunol; 2022; 13():1052542. PubMed ID: 36466925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of systemic immune-inflammation index for pathological complete response in patients receiving neoadjuvant immunochemotherapy for locally advanced esophageal cancer.
    Han W; Weng K; Zhang P; Hong Z
    Front Surg; 2022; 9():1091601. PubMed ID: 36684142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node ratio is a prognostic indicator for locally advanced esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy.
    Chen P; Wang L; Yang X; Feng J
    Biomol Biomed; 2024 Jan; 24(1):159-169. PubMed ID: 37597214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic radiological features predict pathological response after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.
    Ruan Y; Ma Y; Ma M; Liu C; Su D; Guan X; Yang R; Wang H; Li T; Zhou Y; Ma J; Zhang Y
    J Transl Med; 2024 May; 22(1):471. PubMed ID: 38762454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
    Liu G; Chen T; Zhang X; Hu B; Yu J
    Cancer Med; 2024 Mar; 13(5):e7075. PubMed ID: 38477511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers.
    Wu Y; Chen J; Zhao L; Li Q; Zhu J; Yang H; Guo S; Xi M
    Cancer Res Treat; 2021 Jan; 53(1):172-183. PubMed ID: 32898941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual tumor model in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy: Frequently involves the mucosa and/or submucosa.
    Gao L; Hong ZN; Wu L; Yang Y; Kang M
    Front Immunol; 2022; 13():1008681. PubMed ID: 36569913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
    Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical significance of geriatric nutritional risk index in esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy.
    Feng J; Wang L; Yang X; Chen Q; Cheng X
    Eur J Surg Oncol; 2024 Jun; 50(6):108323. PubMed ID: 38603867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive nutritional index predicts clinical outcomes for esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy.
    Feng J; Wang L; Yang X; Chen Q; Cheng X
    Int Immunopharmacol; 2023 Aug; 121():110459. PubMed ID: 37307758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.